Jennison Associates LLC Oric Pharmaceuticals, Inc. Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$4.54 - $16.1 $4.47 Million - $15.9 Million	-985,072 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$12.01 - $20.3 $177,796 - $300,521	-14,804 Reduced 1.48%	985,072 $14.5 Million
Q3 2021 Nov 09, 2021	BUY	$15.9 - $25.22 $46,602 - $73,919	2,931 Added 0.29%	999,876 $20.9 Million
Q2 2021 Aug 12, 2021	SELL	$17.37 - $25.34 $2.55 Million - $3.71 Million	-146,534 Reduced 12.81%	996,945 $17.6 Million
Q1 2021 May 11, 2021	BUY	$23.67 - $36.85 $14.7 Million - $22.8 Million	619,999 Added 118.44%	1,143,479 $28 Million
Q4 2020 Feb 05, 2021	BUY	$20.32 - $39.8 $7.58 Million - $14.8 Million	372,879 Added 247.59%	523,480 $17.7 Million
Q3 2020 Nov 04, 2020	BUY	$19.5 - $31.26 $10,588 - $16,974	543 Added 0.36%	150,601 $3.77 Million
Q2 2020 Aug 06, 2020	BUY	$25.68 - $38.12 $3.85 Million - $5.72 Million	150,058 New	150,058 $5.06 Million

125

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $329M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.